Myalgia (Muscle Pain) Global Clinical Trials Review, H2, 2019
- GDHC5183CTIDB
- Pages: 196
- October 2019
- Total Views:1138
- Region : Global
- GlobalData
- Market Research Report
Details
Myalgia (Muscle Pain) Global Clinical Trials Review, H2, 2019
Summary
GlobalData's clinical trial report, Myalgia (Muscle Pain) Global Clinical Trials Review, H2, 2019" provides an overview of Myalgia (Muscle Pain) clinical trials scenario. This report provides top line data relating to the clinical trials on Myalgia (Muscle Pain). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Content
Scope
Table of Contents
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Myalgia (Muscle Pain) Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 199
Abbreviations 199
Definitions 199
Research Methodology 200
Secondary Research 200
About GlobalData 201
Contact Us 201
Source 202
List Of Figure
List of Figures
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Myalgia (Muscle Pain) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 15
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Myalgia (Muscle Pain) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
GlobalData Methodology 200
List Of Table
List of Tables
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Region, 2019* 7
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Myalgia (Muscle Pain) Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 15
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Phase, 2019* 22
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Myalgia (Muscle Pain) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
Reckitt Benckiser Group Plc
Novartis AG
Teva Pharmaceutical Industries Ltd
Allergan Plc
Mundipharma International Ltd
Eli Lilly and Co
Nanjing Easeheal Pharmaceutical Co Ltd
Accutest Research Laboratories (I) Pvt Ltd
Dr. Reddy's Laboratories Ltd
Gebro Pharma GmbH
Company Profile
Company Profile Title
Myalgia (Muscle Pain) Global Clinical Trials Review, H2, 2019
Summary
GlobalData's clinical trial report, Myalgia (Muscle Pain) Global Clinical Trials Review, H2, 2019" provides an overview of Myalgia (Muscle Pain) clinical trials scenario. This report provides top line data relating to the clinical trials on Myalgia (Muscle Pain). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Table of Contents
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Myalgia (Muscle Pain) Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 199
Abbreviations 199
Definitions 199
Research Methodology 200
Secondary Research 200
About GlobalData 201
Contact Us 201
Source 202
List Of Figure
List of Figures
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Myalgia (Muscle Pain) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 15
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Myalgia (Muscle Pain) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
GlobalData Methodology 200
List Of Table
List of Tables
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Region, 2019* 7
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Myalgia (Muscle Pain) Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 15
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Myalgia (Muscle Pain) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Myalgia (Muscle Pain) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Myalgia (Muscle Pain) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Phase, 2019* 22
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
Myalgia (Muscle Pain) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Myalgia (Muscle Pain) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Myalgia (Muscle Pain) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
Reckitt Benckiser Group Plc
Novartis AG
Teva Pharmaceutical Industries Ltd
Allergan Plc
Mundipharma International Ltd
Eli Lilly and Co
Nanjing Easeheal Pharmaceutical Co Ltd
Accutest Research Laboratories (I) Pvt Ltd
Dr. Reddy's Laboratories Ltd
Gebro Pharma GmbH
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020